Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimum effective concentration of simethicone for upper gastrointestinal endoscopy
ChiCTR2100043397Phase 4Recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of simethicone in duodenal ulcer (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoints: visibility score and subtle lesion detection. Started Feb 2021; status: recruiting.
02
Drugs
simethicone
03
Conditions
duodenal ulcer
Beyond the preview
Go deeper on ChiCTR2100043397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043397.